Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Chronic kidney disease

Oral bicarbonate: renoprotective in CKD?

Preliminary findings suggest that oral sodium bicarbonate administration could become a major addition to the armamentarium of renoprotective measures for individuals with chronic kidney disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kopple, J. D., Kalantar-Zadeh, K. & Mehrotra, R. Risks of chronic metabolic acidosis in patients with chronic kidney disease. Kidney Int. Suppl. S21–S27 (2005).

  2. Nath, K. A., Hostetter, M. K. & Hostetter, T. H. Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J. Clin. Invest. 76, 667–675 (1985).

    Article  CAS  Google Scholar 

  3. de Brito-Ashurst, I., Varagunam, M., Raftery, M. J. & Yaqoob, M. M. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J. Am. Soc. Nephrol. 20, 2075–2084 (2009).

    Article  CAS  Google Scholar 

  4. Kalantar-Zadeh, K., Mehrotra, R., Fouque, D. & Kopple, J. D. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin. Dial. 17, 455–465 (2004).

    Article  Google Scholar 

  5. Bommer, J. et al. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am. J. Kidney Dis. 44, 661–671 (2004).

    Article  Google Scholar 

  6. Wu, D. Y. et al. Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic? Clin. J. Am. Soc. Nephrol. 1, 70–78 (2006).

    Article  CAS  Google Scholar 

  7. Kovesdy, C. P., Anderson, J. E. & Kalantar-Zadeh, K. Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD. Nephrol. Dial. Transplant. 24, 1232–1237 (2009).

    Article  CAS  Google Scholar 

  8. Kovesdy, C. P., George, S. M., Anderson, J. E. & Kalantar-Zadeh, K. Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am. J. Clin. Nutr. 90, 407–414 (2009).

    Article  CAS  Google Scholar 

  9. Kovesdy, C. P. et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 2, 999–1007 (2007).

    Article  CAS  Google Scholar 

  10. Felsenfeld, A. J. & Levine, B. S. Milk alkali syndrome and the dynamics of calcium homeostasis. Clin. J. Am. Soc. Nephrol. 1, 641–654 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kovesdy, C., Kalantar-Zadeh, K. Oral bicarbonate: renoprotective in CKD?. Nat Rev Nephrol 6, 15–17 (2010). https://doi.org/10.1038/nrneph.2009.204

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2009.204

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing